gemcitabine has been researched along with uridine triphosphate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, H; Furman, PA; McBrayer, TR; Micolochick Steuer, HM; Murakami, E; Obikhod, A; Otto, MJ; Ramesh, M; Schinazi, RF; Stuyver, LJ; Whitaker, T | 1 |
| Peters, G; Pinedo, HM; van Haperen, VW; Veerman, G; Vermorken, JB | 1 |
| Bergman, AM; Jensen, PB; Munch-Petersen, B; Peters, GJ; Pinedo, HM; Sehested, M; Smid, K; Veerman, G; Voorn, DA | 1 |
| Cinatl, J; Doerr, HW; Gröschel, B; Höver, G; Kaufmann, A; Loves, WJ; Noordhuis, P; Peters, GJ | 1 |
| Cass, CE; Eriksson, S; Mani, RS; Usova, EV | 1 |
| Beijnen, JH; Derissen, EJB; Huitema, ADR; Rosing, H; Schellens, JHM | 1 |
1 trial(s) available for gemcitabine and uridine triphosphate
| Article | Year |
|---|---|
Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides.
Topics: Activation, Metabolic; Antimetabolites, Antineoplastic; Breast Neoplasms; Cytidine Triphosphate; Deamination; Deoxycytidine; Female; Floxuridine; Gemcitabine; Humans; Leukocytes, Mononuclear; Phosphorylation; Uridine Triphosphate | 2018 |
5 other study(ies) available for gemcitabine and uridine triphosphate
| Article | Year |
|---|---|
Mechanism of activation of beta-D-2'-deoxy-2'-fluoro-2'-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase.
Topics: Antiviral Agents; Catalysis; Deoxycytidine; Hepacivirus; Hepatitis C; Humans; Mutation; Phosphorylation; RNA-Dependent RNA Polymerase; RNA, Viral; Structure-Activity Relationship; Viral Nonstructural Proteins; Virus Replication | 2007 |
Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine.
Topics: Cytidine Deaminase; Cytidine Triphosphate; Deoxycytidine; Deoxycytidine Kinase; Enzyme Inhibitors; Female; Gemcitabine; Humans; Kinetics; Nucleoside Deaminases; Ovarian Neoplasms; Phosphorylation; Tumor Cells, Cultured; Uridine Triphosphate | 1996 |
Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
Topics: Adenosine Triphosphate; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Carcinoma, Small Cell; Cell Survival; Cytarabine; Cytidine Deaminase; Daunorubicin; Deoxycytidine; Deoxycytidine Kinase; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Guanosine Triphosphate; Humans; Lung Neoplasms; Nucleoside Deaminases; Teniposide; Thymidine Kinase; Tumor Cells, Cultured; Uridine Triphosphate | 2001 |
3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.
Topics: Adenosine Triphosphate; Anti-HIV Agents; Blotting, Western; Cytidine Triphosphate; Deoxycytidine; Deoxycytidine Kinase; Drug Resistance, Microbial; Gemcitabine; HIV-1; Humans; RNA, Messenger; T-Lymphocytes; Thymidine Kinase; Uridine Triphosphate; Zidovudine | 2002 |
Fluorescence studies of substrate binding to human recombinant deoxycytidine kinase.
Topics: Adenosine Triphosphate; Antimetabolites, Antineoplastic; Deoxycytidine; Deoxycytidine Kinase; Gemcitabine; Humans; Kinetics; Ligands; Microscopy, Fluorescence; Neoplasms; Phosphates; Phosphorylation; Protein Binding; Protein Conformation; Recombinant Proteins; Spectrometry, Fluorescence; Substrate Specificity; Uridine Triphosphate | 2004 |